PRESS RELEASE: IVI Unveils New Value Assessment Model for Non-Small Cell Lung Cancer

2019-01-31T13:30:16-06:00January 31st, 2019|IVI News, Press|

IVI released our initial version of the new Open-Source Value Platform (OSVP) model for non-small cell lung cancer. Specifically, the model provides information on the relative value of sequential treatments for epidermal growth factor receptor positive (EGFR+), non-squamous non-small cell lung cancer (NSCLC).

The entirety of the IVI-NSCLC model package, including detailed methods documentation, R software package, source code and user interfaces, are available for access and download via IVI’s website.

Our models are developed iteratively with feedback and suggestions from all interested healthcare stakeholders. We invite public input on all aspects of the model during the public comment period, which ends April 1, 2019. All public comments will be reviewed by a Technical Expert Panel (TEP), engaged by IVI to synthesize feedback and recommend prioritized modifications for inclusion in the next model release.

Please contact us at info@thevalueinitiative.org with any questions.

Read the full press release here.